Perioperative triplet chemotherapy plus bevacizumab (bev) in patients with borderline resectable colorectal cancer liver metastases (CLM): Preliminary safety and activity
暂无分享,去创建一个
V. Mazzaferro | M. Milione | F. Braud | A. Mennitto | J. Coppa | M. Caporale | R. Berenato | C. Cotsoglou | M. Bartolomeo | I. Bossi | M. Scotti | P. Filippo